Chronic kidney disease in long-term survivors of hematopoietic cell transplant
Related Experiment Video
Updated: Jul 17, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
S Hingorani1, K A Guthrie, G Schoch
1Department of Pediatrics, University of Washington, Seattle, WA 98105, USA. sangeeta.hingorani@seattlechildrens.org
Insights
Chronic kidney disease (CKD) affects 23% of long-term hematopoietic cell transplant (HCT) survivors. Acute renal failure and graft-vs-host disease significantly increase CKD risk.
Area of Science:
- Nephrology
- Hematology
- Oncology
Background:
- Hematopoietic cell transplantation (HCT) is a life-saving procedure for various hematologic malignancies and other conditions.
- Long-term survivors of HCT face a risk of developing chronic health complications, including kidney disease.
- Identifying risk factors for chronic kidney disease (CKD) post-HCT is crucial for patient management and outcomes.
Purpose of the Study:
- To identify risk factors associated with the development of chronic kidney disease (CKD) in long-term survivors of hematopoietic cell transplant (HCT).
Main Methods:
- A cohort study was conducted involving 1635 patients who underwent HCT between 1991 and 2002.
- CKD was defined as a glomerular filtration rate < 60 ml/min/m(2) on two occasions between days 100 and 540 post-transplant.
- Cox regression models were used to analyze associations between demographic and clinical variables and CKD risk.
Main Results:
- A total of 376 patients (23%) developed CKD at a median of 191 days post-transplant.
- Factors associated with an increased risk of CKD included acute renal failure (ARF) (HR=1.7) and acute graft-vs-host disease (aGVHD) grades II (HR=2.0) and III/IV (HR=3.1).
- Chronic graft-vs-host disease (GVHD) (HR=1.8) was also associated with increased CKD risk, while total body irradiation (TBI) was not (HR=1.0).
Conclusions:
- Chronic kidney disease is a significant concern for long-term survivors of HCT.
- The occurrence of ARF and GVHD are identified as key risk factors for developing CKD after HCT.
- Receipt of TBI was not found to be associated with an increased risk of CKD in this cohort.
Abstract:
We conducted a cohort study to identify risk factors of chronic kidney disease (CKD) among long-term survivors of hematopoietic cell transplant (HCT). We studied 1635 patients transplanted at the Fred Hutchinson Cancer Research Center (FHCRC) between 1991 and 2002, who survived to day +131 after transplant and had serum creatinine measured on at least two occasions after day +131. CKD was defined as a glomerular filtration rate < 60 ml/min/m(2) on two occasions separated by at least 30 days between days 100 and 540 post transplant. Cox regression models estimated hazard ratios (HRs) describing associations between demographic data, clinical variables and the risk of developing CKD. A total of 376 patients (23%) developed CKD at a median of 191 days post transplant (range 131-516 days). An increased risk of CKD was associated with acute renal failure (ARF) (HR=1.7, 95% confidence interval (CI) 1.3-2.1), acute graft-vs-host disease (aGVHD) grade II (HR=2.0, 95% CI 1.4-2.9) and grades III/IV (HR=3.1, 95% CI 2.1-4.6) and chronic GVHD (HR=1.8, 95% CI 1.4-2.2). Total body irradiation (TBI) (HR=1.0, 95% CI 0.8-1.3) was not associated with an increased risk of CKD. CKD is relatively common among survivors of HCT. The presence of ARF and GVHD, but not receipt of TBI, appears to be associated with the occurrence of CKD.
Related Concept Videos
Kidney Transplant I: Introduction
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Kidney Transplant III: Nursing Management
Kidney Transplant II: Surgical Procedure
Chronic Kidney Disease III: Interprofessional Care
